A cross-sectional study evaluating cardiovascular risk and statin prescribing in the Canadian Primary Care Sentinel

Ian S Johnston1,2, Brendan Miles3, Boglarka Soos3

  • 1University of Calgary, Calgary, Canada. ian.johnston2@ucalgary.ca.

BMC Primary Care
|May 25, 2022
PubMed

Insights

High cardiovascular disease (CVD) risk in Canada is linked to older age, male sex, comorbidities, and lower socioeconomic status. Lower socioeconomic groups with high CVD risk may not receive guideline-recommended statin treatment.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Cardiovascular disease (CVD) is a leading cause of death and illness in Canada.
  • Effective CVD risk assessment and management are crucial for reducing disease burden.
  • Socioeconomic factors significantly influence CVD risk and treatment, yet are underreported.

Purpose of the Study:

  • To estimate cardiovascular risk among Canadian primary care patients.
  • To evaluate statin prescribing patterns based on CVD risk and socioeconomic status (SES).
  • To assess adherence to clinical practice guidelines for CVD treatment.

Main Methods:

  • Cross-sectional observational study using the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) database.
  • Included 324,526 patients aged 35-75 years (2012-2016).
  • Assessed CVD risk categories and socioeconomic deprivation quintiles; analyzed statin prescription concordance with guidelines using logistic regression.

Main Results:

  • 36% of patients were categorized as high CVD risk, predominantly older males with comorbidities.
  • High CVD risk was disproportionately concentrated in the most deprived socioeconomic quintile (OR 1.4).
  • 48% of high-risk patients received statin prescriptions; lower SES groups showed guideline deviations in treatment.

Conclusions:

  • High CVD risk patients are more likely to be male, older, have comorbidities, and belong to deprived socioeconomic groups.
  • Patients facing socioeconomic challenges may receive CVD treatments less aligned with clinical guidelines.
  • Addressing socioeconomic disparities is vital for equitable CVD risk management and treatment.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
41
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
134
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
900
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
480
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
44
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
185